The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer

Reduced expression of MUTYH with suppressive activity against mutations caused by 8-hydroxyguanine is a novel predictor of a poor prognosis in human gastric cancer

(2011) Kazuya Shinmura et al.   JOURNAL OF PATHOLOGY

Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase

(2010) Hagop M. Kantarjian et al.   CANCER

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

(2010) John Araujo et al.   CANCER TREATMENT REVIEWS

The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia

(2010) S. Nakamura et al.   CARCINOGENESIS

NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors

(2010) Vivian Y. Shin et al.   CARCINOGENESIS

p57 Kip2 is a downstream effector of BCR–ABL kinase inhibitors in chronic myelogenous leukemia cells

(2010) Adriana Borriello et al.   CARCINOGENESIS

Adenine DNA glycosylase activity of 14 Human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancer

(2010) Masanori Goto et al.   HUMAN MUTATION

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

(2010) Håkan Norell et al.   Journal of Translational Medicine

NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer

(2010) Joanne Holden et al.   LANCET ONCOLOGY

Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a ‘head-to-head comparison’

(2010) Gianantonio Rosti et al.   LEUKEMIA & LYMPHOMA

Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives

(2010) Haruhiko Sugimura et al.   PATHOLOGY INTERNATIONAL

A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth

(2009) Hiroaki Mita et al.   BMC CANCER

Crk and CrkL adaptor proteins: networks for physiological and pathological signaling

(2009) Raymond B Birge et al.   Cell Communication and Signaling

Copy number estimation algorithms and fluorescencein situhybridization to describe copy number alterations in human tumors

(2009) Masaya Suzuki et al.   PATHOLOGY INTERNATIONAL

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells

(2008) J.-C. Ko et al.   CARCINOGENESIS

Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer

(2008) M Iwaizumi et al.   GUT

Gene expression of AGS cells stimulated with released proteins by Helicobacter pylori

(2008) Nayoung Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Induction of centrosome amplification and chromosome instability inp53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE)

(2008) K Shinmura et al.   JOURNAL OF PATHOLOGY

HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells

(2008) Yuya Sugimoto et al.   LEUKEMIA RESEARCH

Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer

(2008) Hiromi Sakamoto et al.   NATURE GENETICS

MYC and gastric adenocarcinoma carcinogenesis

(2008) Danielle Queiroz Calcagno et al.   WORLD JOURNAL OF GASTROENTEROLOGY